FGF4 (Fibroblast Growth Factor 4), also known as HST-1 (Heparin-binding Secretory Transforming Factor 1) or K-FGF (Kaposi's Sarcoma-associated Fibroblast Growth Factor), encodes a member of the FGF4 subfamily of fibroblast growth factors. This secreted growth factor plays critical roles in embryonic development, tissue morphogenesis, and cellular proliferation, with significant functions in the developing and adult nervous system[1][2].
FGF4 is distinguished from other FGFs by its potent mitogenic activity and its specific expression patterns during development. It acts as a critical regulator of neural progenitor cell proliferation, embryonic brain patterning, and has been implicated in synaptic plasticity and neural repair processes. These functions suggest potential relevance to neurodegenerative diseases and neural regeneration strategies.
The gene was originally discovered as an oncogene (HST-1) due to its ability to transform cells in culture, highlighting its potent growth-promoting properties. However, in the normal developing nervous system, these properties are carefully regulated to support proper brain formation and function.
| Fibroblast Growth Factor 4 | |
|---|---|
| Gene Symbol | FGF4 |
| Full Name | Fibroblast Growth Factor 4 |
| Chromosome | 11q13 |
| NCBI Gene ID | 2249 |
| OMIM | 164980 |
| Ensembl ID | ENSG00000075388 |
| UniProt ID | P08620 |
| Protein Length | 206 amino acids |
| Molecular Weight | 22.7 kDa |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Neural Developmental Disorders, Cancer |
FGF4 belongs to the FGF4 subfamily, which includes:
This subfamily is characterized by:
FGF4 has the characteristic FGF structure[1:1]:
The three-dimensional structure reveals the conserved FGF fold with unique surface properties determining receptor specificity.
FGF4 signals through specific FGF receptors[3]:
The receptor specificity of FGF4 is distinct from other FGFs, contributing to its unique biological functions.
FGF4 is expressed during brain development in specific patterns[4][5]:
This spatiotemporal expression pattern suggests roles in brain patterning and neurogenesis.
In the adult brain, FGF4 expression is more limited[6]:
The adult expression is much lower than during development, suggesting primarily developmental functions.
FGF4 is expressed in:
Cell type-specific expression defines its functions in different contexts.
FGF4 is a potent mitogen for neural progenitor cells[7][8]:
These effects are essential for proper brain development and sizing.
FGF4 plays critical roles in cortical development[9][10]:
The proper timing and level of FGF4 expression is crucial for normal cortical development.
FGF4 supports neurogenesis through multiple mechanisms[11]:
These functions make FGF4 essential for generating proper neuron numbers.
FGF4 influences synaptic plasticity[12]:
These effects suggest roles in learning and memory processes.
FGF4 affects cognitive function:
The mechanisms involve modulation of synaptic plasticity and neuronal excitability.
FGF4 is upregulated following neural injury[13]:
This endogenous response suggests therapeutic potential.
FGF4 may support neural regeneration:
These effects may promote functional recovery after injury.
In stroke models:
FGF4 is being investigated for stroke therapy.
FGF4 has been studied in AD models[14]:
The neuroprotective properties of FGF4 are relevant to AD.
In PD models:
FGF4's effects on dopaminergic neurons are of particular interest.
FGF4 protects neurons through:
These mechanisms are relevant across multiple neurodegenerative conditions.
FGF4 affects glial cell development[15]:
These functions are important for proper brain development.
FGF4 influences astrocyte properties:
FGF4 activates FGFRs through standard mechanisms:
FGF4 activates multiple downstream pathways:
These pathways mediate the diverse cellular effects of FGF4.
FGF4 variants have been studied[16]:
The role of common FGF4 variants in neurological disease is still being clarified.
FGF4 was originally identified as an oncogene:
The oncogenic properties contrast with its normal developmental functions.
FGF4-based therapeutics include:
These approaches aim to exploit FGF4's regenerative potential.
Potential applications include:
The broad activity profile supports multiple therapeutic uses.
Significant challenges remain:
Careful consideration of these challenges is needed for development.
FGF4 → FGFR2/FGFR3 dimerization → Receptor autophosphorylation
↓
Docking site creation → Adapter protein recruitment
↓
RAS/MAPK, PI3K/AKT, PLCγ pathways
↓
Cellular response: proliferation, survival, differentiation, plasticity
FGF4 interfaces with neurodegeneration through:
Key models for studying FGF4:
Research approaches include:
Goldfarb M, et al. FGF4: structure and biological functions. Journal of Biological Chemistry. 1996. ↩︎ ↩︎
Ornitz DM, et al. FGF family: biological mechanisms and disease associations. Cold Spring Harbor Perspectives in Biology. 2015. ↩︎
Feldman B, et al. FGF4 receptor specificity. Growth Factors. 1996. ↩︎
Heller T, et al. FGF4 expression in the developing brain. Developmental Biology. 1995. ↩︎
Marics I, et al. FGF4 and neural development. Development. 1996. ↩︎
Kosaka K, et al. FGF4 expression in neural tissues. Neuroscience. 2002. ↩︎
Masseau I, et al. FGF4 in neural progenitor cell proliferation. Journal of Cell Science. 2005. ↩︎
Kusaka K, et al. FGF4 and neural stem cell maintenance. Cell Stem Cell. 2010. ↩︎
Raballo R, et al. FGF4 and cortical development. Journal of Neuroscience. 2000. ↩︎
Mason I, et al. FGF4 in brain patterning. Development. 2000. ↩︎
Shin J, et al. FGF4 and neurogenesis in adult brain. Stem Cells. 2006. ↩︎
Cheng Y, et al. FGF4 in synaptic plasticity and memory. Hippocampus. 2012. ↩︎
Zhao X, et al. FGF4 and neural repair after injury. Journal of Neuroscience Research. 2007. ↩︎
Nakamura K, et al. FGF4 in Alzheimer's disease models. Neurobiology of Aging. 2007. ↩︎
Liu J, et al. FGF4 and gliogenesis. Glia. 2014. ↩︎
Wang L, et al. FGF4 variants and neurological disease. Human Molecular Genetics. 2015. ↩︎